Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.40

+5.5%

Nov 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Galirayo who wrote (621)	1/16/2005 1:44:38 PM
From: scaram(o)uche	Read Replies (1) of 3722

Biomaven follows RGEN. Used to be one of my faves, but then they went into autism, about which I know nothing. Biomaven correctly points to a use claim (patent) for ctla4Ig, a molecule that BMY has in advanced clinical testing. the point? ctla4Ig seems to be making more noise of late. hard working, devoted management team, constantly fighting uphill.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next